Pathological diagnosis of early colorectal carcinoma and its clinical implications

Digestion

Volumn 79, Issue SUPPL. 1, 2009, Pages 40-51

  Fujimori, Takahiro ^a   Fujii, Shigehiko ^a   Saito, Natsuko ^a   Sugihara, Kenichi ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Budding sprouting; Colorectal submucosal invasive carcinomas; Depth of invasion; Endoscopic treatment

Indexed keywords

MUCIN; PROTEIN P53;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURGERY; COLON RESECTION; COLORECTAL CARCINOMA; CONFERENCE PAPER; DISEASE CLASSIFICATION; ENDOSCOPIC SURGERY; GENETIC ANALYSIS; HAGGITT CLASSIFICATION; HUMAN; LYMPH NODE METASTASIS; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VILLOUS ADENOMA; VISCERAL METASTASIS;

ADENOMA, VILLOUS; CARCINOMA; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; RECTUM;

EID: 58549113780     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167865     Document Type: Conference Paper

References (50)

1. Kawamata H, Tachibana M, Fujimori T, Imai Y: Differentiation-inducting therapy for solid tumors. Curr Pharm Design 2006;12:379-385.
2. Kudo S: Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993;25:455-461.
3. Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T: Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. J Gastroenterol Hepatol 2000;15:1151-1157.
4. Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, Kumamoto T, Ishiguro S, Kato Y, Shimoda T, Iwashita A, Ajioka Y, Watanabe H, Watanabe T, Muto T, Nagasako K: Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 2004;39:534-543.
5. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histophathology 2002;40:127-132.
6. Masaki T, Matsuoka H, Sugiyama M, Abe N, Atomi Y, Sakamoto A: New prognostic markers in submucosally invasive colorectal carcinomas: clinical implication of tumor budding; in Muto T, Mochizuki H, Masaki T (eds): Tumor Budding in Colorectal Cancer. New York, Nova Science Publishers Inc., 2006, pp 139-150.
7. Nishi M, Moriyasu F: Clinicopathological study for reevaluation of the depth of submucosal invasion and histological classification of early colorectal cancer (in Japanese with English abstract). Jpn J Gastroenterol 2002;99:769-778.
8. Matsuda T, Fujii T, Ikehara H, Kouzu T, Kadokawa Y, Kobayashi M, Ohtake Y, Ohno A, Ikematsu H, Uraoka T, Furuya T, Hasuda K, Hotta K, Oda I, Gotouda T, Yamaguchi H, Saito D, Saito Y: Ip Isp type early colorectal cancer - diagnosis of depth of invasion for selection of treatment modality (in Japanese with English abstract). Stomach Intest 2002;37:1559-1570.
9. Nishikura K, Watanebe H, Iwafuchi M, Ajioka Y, Hashidate H, Tanabe T, Shiroshita H, Aihara R, Kijima H: Historical overview of the classification of gastric carcinoid (in Japanese with English abstract). Stomach Intest 2000;35:1349-1354.
10. Kono T, Imai Y, Imura J, Ono Y, Hagiwara S, Taira K, Fujita M, Tsubaki M, Sunagawa M, Fujimori T: Cecal adenocarcinoma with prominent rhabdoid feature: report of a case with immunohistochemical, ultrastructual and molecular analyses. Int J Surg Pathol 2007;15:414-420.
11. Kaihara T, Kawamata H, Imura J, Fujii S, Kitajima K, Omotehara F, Maeda N, Nakamura T, Fujimori T: Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1. Cancer Sci 2003;94:166-172.
12. Kaihara T, Kusaka T, Nishi M, Kawamata H, Imura J, Kitajima K, Itoh-Minami R, Aoyama N, Kasuga M, Oda Y, Hattori M, Fujimori T: Defferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis. J Exp Clin Cancer Res 2003;22:117-123.
13. Hirohashi S: Inactivasion of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339.
14. Imai T: Growth patterns in human carcinoma: their classification and relation to prognosis. Obstet Gynecol 1960;16:296-308.
15. Ichikawa K, Fujimori T, Chibana Y, Fujii S, Iida M, Ohkura Y, Hori H, Kuroda Y, Sakai Y: In the field of gastrointestinal pathology; in Muto T, Mochizuki H, Masaki T (eds): Tumor Budding in Colorectal Cancer. New York, Nova Science Publishers Inc., 2006, pp 3-13.
16. Tanaka S, Haruma K, Oh-E H, Nagata S, Hirota Y, Furudoi A, Amioka T, Kitadai Y, Yoshihara M, Shimamoto F: Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion. Oncol Rep 2000;7:783-788.
17. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 1998;319:525-532.
18. Thun MJ, Namboodiri MM, Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-1596.
19. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM: Suppression of intestinal polyposis in APC delta 716 knockout mice by inhibition of cycloxygenase 2 (COX-2). Cell 1996;87:803-809.
20. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Frerrenbach S, Dubois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-1188.
21. Fujita M, Fukui H, Kusaka T, Morita K, Fujii S, Ueda Y, Chiba T, Sakamoto C, Kawamata H, Fujimori T: Relationship between cyclooxygenase (COX)-2 expression and K-ras gene mutation in colorectal adenomas. J Gastroenterol Hepatol 2000;15:1277-1281.
22. Mukawa K, Fujii S, Tominaga K, Toshitake N, Abe A, Kono T, Sekikawa A, Ichikawa K, Tomita S, Imura J, Ono Y, Shinoda M, Hiraishi H, Fujimori T: Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Oncol Rep 2008;19:393-399.
23. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B: Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 2001;98:2640-2645.
24. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato Y, Kogawa K, Miyake H, Niitsu Y: Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339:1277-1284.
25. Fujimori T, Fujii S, Kitajima K, Nishi M, Sano Y: Initial transformed cells of colorectal adenoma: do they occur at the top of the crypt? J Gastroenterol 2002;37:982-984.
26. Takeda J, Kawamata H, Fujimori T: Is the term 'ACF' necessary in humans? J Gastroenterol 2004;39:400-401.
27. Pronk GJ, Bos JL: The role of p21ras in receptor tyrosine kinase signalling. Biochim Biophys Acta 1994;1198:131-147.
28. Fujimori T, Satonaka K, Yamamura-Idei Y, Nagasako K, Maeda S: Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int J Cancer 1994;57:51-55.
29. Fujimori T, Ono Y, Sakuma K, Ueda Y, Terano A: Genetic changes in colorectal adenoma and cancer in relation to various morphologic aspects. J Gastroenterol 1998;33:804-810.
30. Goto H, Oda Y, Murakami Y, Tanaka T, Hasuda K, Goto S, Sasaki Y, Sakisaka S, Hattori M: Proportion of de novo cancers among colorectal cancers in Japan. Gastroenterology 2006;131:40-46.
31. Ishii M, Sugai T, Habano W, Nakamura S: Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas. J Gastroenterol 2004;39:544-549.
32. Yukawa M, Fujimori T, Maeda S, Tabuchi M, Nagasako K: Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumors. Gut 1994;35:1258-1261.
33. Levine AJ: p53, the cellular gate-keeper for growth and division. Cell 1997;88:323-331.
34. Fujii S, Katsumata D, Fujimori T: Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia. Digestion 2008;77:2-12.
35. Fujii S, Fujimori T, Chiba T: Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. J Exp Clin Cancer Res 2003;22:107-115.
36. Fujimori T, Kawamata H, Kashida H: Precancerous lesions of the colorectum. J Gastroenterol 2001;36:587-594.
37. Furihata T, Sakai T, Kawamata H, Omotehara F, Shinagawa Y, Imura J, Ueda Y, Kubota K, Fujimori T: A New in vivo model for studying invasion and metastasis of esophageal squamous cell carcinoma. Int J Oncol 2001;19:903-907.
38. Yoshitake N, Fukui H, Yamagishi H, Sekikawa A, Fujii S, Tomita S, Ichikawa K, Imura J, Hiraishi H, Fujimori T: Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Brit J Cancer 2008;98:1682-1689.
39. Zeelenberg IS, Ruuls-Van Stalle L, Roos E: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003;63:3833-3839.
40. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008;68:918-926.
41. Japanese Society for Cancer of the Colon and Rectum (ed): General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus (ed 7). Japanese Classification of Colorectal Carcinoma. Tokyo, Kanehara, 2006.
42. Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50:6130-6138.
43. Rabban JT, Chen YY: D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. Hum Pathol 2008;39:175-183.
44. Kudo S, Soga J, Yamamoto M, Koyama S Muto T: Treatment of colorectal sm- carcinomas (in Japanese with English abstract). Stomach Intest 1984;19:1349-1355.
45. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD: Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;89:328-336.
46. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y: Management of early invasive colorectal cancer: risk of recurrence and clinical guidelines. Dis Colon Rectum 1995;38:1286-1295.
47. Tamura S, Onishi S: Laterally spreading colon cancer. N Engl J Med 2004;351:e24.
48. Rashid A, Zahurak M, Goodman SN, Hamilton SR: Genetic epidemiology of mutated K-ras protooncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 1999;44:826-833.
49. Yao T, Kajiwara M, Kouzuki T, Iwashita A, Tsuneyoshi M: Villous tumor of the colon and rectum with special reference to roles of p53 and Bcl-2 in adenoma-carcinoma sequence. Pathol Int 1999;49:374-382.
50. Arai T, Kino I: Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 1995;176:37-44.